NCT00939484 2016-02-25Vismodegib in Treating Patients With Recurrent or Refractory MedulloblastomaNational Cancer Institute (NCI)Phase 2 Completed31 enrolled 13 charts
NCT01239316 2016-01-14Vismodegib in Treating Younger Patients With Recurrent or Refractory MedulloblastomaNational Cancer Institute (NCI)Phase 2 Completed12 enrolled 11 charts